*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : MY8434000
CHEMICAL NAME : Hydroxylapatite (Ca5(OH)(PO4)3) (9CI)
CAS REGISTRY NUMBER : 1306-06-5
LAST UPDATED : 199806
DATA ITEMS CITED : 7
MOLECULAR FORMULA : Ca5-H-O13-P3
MOLECULAR WEIGHT : 502.32
COMPOUND DESCRIPTOR : Mutagen
SYNONYMS/TRADE NAMES :
* Alveograf
* Apatite, hydroxy
* Durapatite
* Hydroxyapatite
* Monite
* Periograf
* Supertite 10
* Win 40350
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >25350 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1007,1995
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >19850 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1007,1995
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >99500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1007,1995
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >25500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1007,1995
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >30 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1007,1995
** MUTATION DATA **
TYPE OF TEST : DNA adduct
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 200 mg/L
REFERENCE :
IJBBBQ Indian Journal of Biochemistry and Biophysics. (Publications &
Information Directorate, CSIR, Hillside Rd., New Delhi 110 012, India) V.8-
1971- Volume(issue)/page/year: 19,71,1982
*** STATUS IN U.S. ***
EPA TSCA Section 8(b) CHEMICAL INVENTORY
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Hydrouracil, 5-methyl-1-(p-propoxybenzyl)-2-thio-
| 63884-36-6 |
Hydrazine, 1-isonicotinoyl-2-(2-thenoyl)-
| 91093-48-0 |
Hydrouracil, 1-nitroso-
| 16813-36-8 |
Hydrouracil, 3-octyl-2-thio-
| 5540-66-9 |
Hydrouracil, 1-(p-propoxybenzyl)-
| 5540-66-9 |
Hydrouracil, 1-(p-propoxybenzyl)-2-thio-
| 5540-66-9 |
Hydroxamic acid, benzsulfo-
| 599-71-3 |
Hydroxamic acid, di-, diglycolate
| 599-71-3 |
Hydroxamic acid, N-dimethylglycinate, methochloride
| 599-71-3 |
Hydroxamic acid, N-fluoren-2-yl-N-tetradecanoyl-
| 32766-75-9 |
Hydroxamic acid, glucuronate
| 32766-75-9 |
Hydroxamic acid, glycinate
| 32766-75-9 |
Hydrazine, 1-isonicotinoyl-2-undecanoyl-
| 32766-75-9 |
Hydroxamic acid, histidinate
| 32766-75-9 |
Hydroxamic acid, lactate
| 32766-75-9 |
Hydroxamic acid, mandelate
| 32766-75-9 |
Hydroxamic acid, nicotinate
| 32766-75-9 |
Hydroxamic acid, nicotinate, benzobromide
| 32766-75-9 |
Hydroxamic acid, nicotinate, methiodide
| 32766-75-9 |
Hydroxamic acid, picolate
| 32766-75-9 |
Hydroxamic acid, polyacrylate
| 32766-75-9 |
Hydroxamic acid, serinate
| 32766-75-9 |
Hydroxamic acid, sorbate
| 32766-75-9 |
Hydrazine, 1-(4-isopropylbenzyl)-
| 51860-03-8 |
Hydroxamic acid, tartrate
| 51860-03-8 |
Hydroxylapatite (Ca5(OH)(PO4)3) (9CI)
| 1306-06-5 |
Hydroxylamine
| 7803-49-8 |
Hydroxylamine, N-acetyl-O-benzoyl-
| 76412-58-3 |
Hydroxylamine, O-acetyl-N-benzoyl-
| 21251-12-7 |
Hydroxylamine, N-acetyl-O-benzoyl-N-fluoren-2-yl-
| 6098-45-9 |
Hydroxylamine, O-acetyl-N-(p-butoxyphenylacetyl)-
| 77372-67-9 |
Hydroxylamine,O-acetyl-N-(m-chlorophenyl)-N-(methylcarbamoyl)-
| 13790-09-5 |
Hydroxylamine,O-acetyl-N-(p-chlorophenyl)-N-(methylcarbamoyl)-
| 22169-00-2 |
Hydroxylamine,O-acetyl-N-ethyl-N-(alpha-methyl-m-(trifluoromethyl)phenethyl)-
| 94593-30-3 |
Hydrazine, (2-(diphenylmethylsulfonyl)ethyl)-
| 7271-99-0 |
Hydrazine, (alpha-isopropylbenzyl)-, oxalate (11)
| 7271-99-0 |
Hydroxylamine, O-acetyl-N-isonicotinoyl-
| 89970-85-4 |
Hydroxylamine, O-acetyl-N-(methylcarbamoyl)-N-phenyl-
| 13748-48-6 |
Hydroxylamine,O-acetyl-N-methyl-N-(p-(phenylazo)phenyl)-
| 55936-77-1 |
Hydroxylamine, O-acetyl-N-(2-naphthoyl)-
| 76749-37-6 |
Hydroxylamine, O-acetyl-N-nicotinoyl-
| 89970-84-3 |
Hydroxylamine, O-acetyl-N-nitro-
| 101976-64-1 |
Hydroxylamine, O-acetyl-N-(p-nitrobenzoyl)-
| 1613-81-6 |
Hydroxylamine,O-acetyl-N-((5-nitro-2-furyl)formimidoyl)-
| 63-69-4 |
Hydroxylamine, O-acetyl-N-picolinoyl-
| 89970-83-2 |
Hydroxylamine, O-acetyl-N-propionyl-
| 76412-59-4 |
Hydrazine, 1-isopropyl-, hydrochloride
| 73941-11-4 |
Hydroxylamine, O-(1-adamantylcarbamoyl)-N-carbamoyl-
| 73941-11-4 |
Hydroxylamine,N-(4-(4-amino-3-chlorobenzyl)-2-chlorophenyl)-
| 73941-11-4 |
Hydroxylamine, N-(2-amino-9H-purin-6-yl)-N-methyl-
| 60254-49-1 |
|
|